Menon R, David BG. Clinical, Cosmetic and Investigational Dermatology. 2015;8:215–222.
On page 215, please note correspondence should have been listed as: Roshni Menon, D II/17, JIPMER Campus, Dhanvanthri Nagar, Pondicherry, India 605006 Tel +91 944 320 8140 Email roshnijagdish@gmail.com
On page 215, the first sentence of the Introduction was “Psoriasis is a chronic inflammatory disease of the skin characterized by exacerbations and remissions affecting 1%–3% of the world’s population, and approximately 20% of patients have moderate to severe disease.1,2” however should have been “Psoriasis is a chronic inflammatory disease of the skin characterized by exacerbations and remissions affecting 1%–3% of the world’s population. Approximately 20% of patients have moderate to severe disease.1,2”
On page 217, 219, and 221 the running header was “Itolizumab – aCD6 monoclonal antibody for the treatment of psoriasis” however should have been “Itolizumab – a humanized anti CD6 monoclonal antibody for the treatment of psoriasis”.
On page 218, Table 1, the second column heading was listed as “Anand et al25 n=40 (moderate–severe psoriasis)” however should have been “Anand et al25 n=40/32 weeks (moderate–severe psoriasis)”.